EUVIMEDEUVIMED entdecken
Crossref

LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation

Yuqi Liu, Dan Feng, Fenfen Liu, Yun Liu, Fangya Zuo, Yujie Wang, Lanlan Chen, Xiuhong Guo, Jinyong Tian

Gerontology · 2024

DOI: 10.1159/000541719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gerontology, 2024. Verfasst von Yuqi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Suppressor of Cytokine Signaling 3 Protein, DNA Methylation, Disease Progression. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been shown to be involved in Parkinson’s disease (PD) progression, but its mechanism needs to be further explored.

Methods

Mice were injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to induce PD mice models, and BV2 cells were treated with lipopolysaccharides (LPS) to mimic PD cell models. MALAT1 expression and suppressor of cytokine signaling 3 (SOCS3) protein level were examined using quantitative real-time PCR and Western blot, respectively. Cell functions were tested by cell counting kit 8 assay and flow cytometry. The interaction between MALAT1 and SOCS3 was confirmed using RNA pull-down and RIP assays.

Results

MALAT1 was upregulated in MPTP-induced PD mice and LPS-induced BV2 cells. Silencing of MALAT1 increased viability, while inhibiting apoptosis and inflammation in LPS-induced BV2 cells. Besides, MALAT1 enhanced the SOCS3 promoter methylation to decrease its expression by recruiting DNMT1, DNMT3A, and DNMT3B. Furthermore, SOCS3 knockdown eliminated sh-MALAT1-mediated the inhibition effect on LPS-induced BV2 cell injury. In vivo, MALAT1 silencing ameliorated neurological impairment and neuroinflammation in MPTP-induced PD mice.

Conclusion

Our data revealed that MALAT1 worsened PD processes via inhibiting SOCS3 expression by increasing its promoter methylation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingSuppressor of Cytokine Signaling 3 ProteinDNA MethylationDisease ProgressionAnimalsMiceMaleMice, Inbred C57BLPromoter Regions, GeneticDisease Models, AnimalLipopolysaccharidesParkinson DiseaseApoptosisUp-RegulationCell Line

Stichwörter der Autor:innen

MALAT1MethylationParkinson’s diseaseSOCS3

Substanzen

RNA, Long NoncodingSuppressor of Cytokine Signaling 3 ProteinMalat1 long non-coding RNA, mouseSocs3 protein, mouseLipopolysaccharides

Autor:innen und Institutionen

  • The First Clinical Medical College of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • General Medicine Department, Guizhou Provincial People's Hospital, Guiyang, China.
  • Zunyi Medical University, Zunyi, China.

Zitieren

APA

Liu, Y., Feng, D., Liu, F., Liu, Y., Zuo, F., Wang, Y., Chen, L., Guo, X., & Tian, J. (2024). LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation. Gerontology. https://doi.org/10.1159/000541719

Vancouver

Liu Y, Feng D, Liu F, Liu Y, Zuo F, Wang Y, et al. LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation. Gerontology. 2024. doi:10.1159/000541719

BibTeX
@article{Liu2024,
  author = {Liu, Yuqi and Feng, Dan and Liu, Fenfen and Liu, Yun and Zuo, Fangya and Wang, Yujie and Chen, Lanlan and Guo, Xiuhong and Tian, Jinyong},
  title = {LncRNA MALAT1 Facilitates Parkinson’s Disease Progression by Increasing SOCS3 Promoter Methylation},
  journal = {Gerontology},
  year = {2024},
  doi = {10.1159/000541719}
}
Kostenlos starten →